MedTrace Logo

Bright Light Therapy During Residential Alcohol Withdrawal

NCT06878287 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-03-14

No results posted yet for this study

Summary

This is a randomized controlled trial assessing the effectiveness of light therapy versus placebo in patients undergoing alcohol withdrawal.

Conditions

Interventions

OTHER

Light exposure

30 minutes morning exposure to light (10 000 lux) using a light-box device filtering UV (CE marking)

OTHER

Placebo light

30 minutes exposure to the same device using a filter inactivating light intensity (\< 10 lux)

Sponsors & Collaborators

  • Centre Hospitalier St Anne

    lead OTHER

Principal Investigators

  • Pierre Alexis GEOFFROY, PhD · University Hospital Group for Psychiatry and Neurosciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-31
Primary Completion
2025-05-31
Completion
2025-05-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06878287 on ClinicalTrials.gov